PubMed HealthSearch

PubMed · 7040579

Stereotactic neurosurgery using 3-D image data from computed tomography.

Abstract

During the last decade computer tomography (CT) scanners have provided images that show internal anatomy of unsurpassed resolution and that, since they are inherently digital, a format computer graphics software can easily process. By combining CT images, a specially designed head-mounted instrument, and the software to coordinate them, improved surgical accuracy can result for stereotactic surgery. Using the head-mounted frame and the interactive computer software described here, the entire stereotactic approach is transportable to computer systems of three major CT manufacturers. Neurosurgeons now have a tool that allows trajectory selection and probe placement entirely within the CT suite. Compared with conventional stereotaxis, the CT-aided approach offers increased accuracy, with a significant fluid contrast injection for finding reference points and the avoidance of important brain structures due to the direct visualization afforded with CT. Key interactive features are shown here that allow unrestricted views of anatomy in the area of surgical interest. For example, oblique views that are normal to the trajectory of neurosurgical instruments are extracted in real time during the surgical procedure. Standard sagittal (lateral) and coronal (frontal) image planes are also shown integrated with the interactive technique. The surgical procedure is outlined and details of the pattern recognition technique for image-to-frame registration are presented. Test, phantom, and patient results are given.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M L Rhodes, W V Glenn, Y M Azzawi, R Slater. 1982. Stereotactic neurosurgery using 3-D image data from computed tomography.. https://doi.org/10.1007/bf00994124

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain

Canada's largest magnet finds home in new MRI program in London.

Canada's largest magnet, which is now making functional magnetic resonance imaging possible at Ontario's Robarts Research Centre, is expected to cast some light on mysteries buried within the brain. With the huge magnet, said Dr. Ravi Menon, "I can distinguish between centres that control the thumb and the index finger."

Brain